Home | Welcome to Contract Pharma   
Last Updated Friday, March 27 2015

Print

Breaking News

March 27, 2015
Eye injection receives FDA approval for the treatment of diabetic retinopathy in patients with diabetic macular edema  Read More »
March 27, 2015
Will use RXi's self-delivering RNAi technology to develop cell-based immunotherapies to treat cancer  Read More »
March 27, 2015
Launch of first etanercept biosimilar reduces the cost of treatment down to 50 percent  Read More »
March 26, 2015
Fully operational to supply comprehensive immunotherapeutic treatments  Read More »
March 26, 2015
Evotec will screen several ion channel targets  Read More »
March 26, 2015
Yordon retires, Kung to serve as chairman  Read More »
March 26, 2015
Expands safety management solutions   Read More »
March 26, 2015
Combined service offering aims to speed drug development and reduce costs  Read More »
March 25, 2015
Will evaluate the safety, tolerability and pharmacokinetics in advanced liver cancer  Read More »
March 25, 2015
Will receive as much as ÂŁ652,000 to expand bioproduction research  Read More »
March 25, 2015
Triggers $7 million BARDA milestone  Read More »
March 24, 2015
Establishes U.S. subsidiary in Boston.  Read More »
March 24, 2015
Sponsors and CRO strategic partners drive RTP expansion.   Read More »
March 24, 2015
Bangalore oral solids manufacturing facility complied with all FDA requirements  Read More »
March 23, 2015
Mazzola brings 25 years of experience  Read More »



Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On